Publisher
Springer Science and Business Media LLC
Reference97 articles.
1. Gaspar VP, Ibrahim S, Zahedi RP, Borchers CH. Utility, promise, and limitations of liquid chromatography-mass spectrometry-based therapeutic drug monitoring in precision medicine. J Mass Spectrom. 2021;56(11): e4788.
2. Clarke W. Overview of therapeutic drug monitoring. In: Clarke W, Dasgupta A, editors. Clinical challenges in therapeutic drug monitoring. New York: Elsevier; 2016. p. 1–13.
3. Capiau S, Alffenaar J-W, Stove C. Alternative sampling strategies for therapeutic drug monitoring. In: Clarke W, Dasgupta A, editors. Clinical challenges in therapeutic drug monitoring. New York: Elsevier; 2016. p. 279–323.
4. Reynolds F, Ziroyanis PN, Jones NF, Smith SE. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet. 1976;2(7982):384–6.
5. Avataneo V, Fanelli E, De Nicolo A, Rabbia F, Palermiti A, Pappaccogli M, et al. A non-invasive method for detection of antihypertensive drugs in biological fluids: the salivary therapeutic drug monitoring. Front Pharmacol. 2021;12: 755184.